Vacina contra o hiv com base em células t alogênicas para induzir a imunidade celular e humoral

vacina contra o hiv com base em células t alogênicas para induzir a imunidade celular e humoral. a presente invenção se refere aos métodos para o tratamento de um paciente que tem o vírus da imunodeficiência humana (hiv) que compreendem administrar composições celulares que compreendem células alogê...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	GUMRUKCU SERHAT
Format:	Patent
Sprache:	por
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	GUMRUKCU SERHAT
description	vacina contra o hiv com base em células t alogênicas para induzir a imunidade celular e humoral. a presente invenção se refere aos métodos para o tratamento de um paciente que tem o vírus da imunodeficiência humana (hiv) que compreendem administrar composições celulares que compreendem células alogênicas recombinantes, tais como células cd4+t. a presente invenção se refere ainda a composições e métodos para produzir uma vacina protetora contra o hiv com base em células t alogênicas que induz à imunidade celular e humoral. Provided herein are methods for treating a patient with human immunodeficiency virus (HIV), comprising administering cellular compositions comprising recombinant allogeneic cells, such as CD4+ T cells. The present invention further relates to compositions and methods for making an allogeneic T-cell-based protective HIV vaccine that induces both cellular and humoral immunity. Related compositions and methods for modulating the immune system using such recombinant cells are also provided.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112021025286A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112021025286A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112021025286A23</originalsourceid><addsrcrecordid>eNqNyjsKAjEUheE0FqLu4TaWwiSi2Koo1iK2wzW54wTyIg8Ld6TbmI0ZwQVYnfPDN2Z4RakdgvQuRwQPvX7UsHDDREAW5PAyxWCCDGj8fXg7LWsFrFo7VZ46Qn22OK1QEUj68ggEfbE-opmyUYcm0ey3EzY_Hi7704KCbykFlOQot7sz56IRvBErsVlvxfJf9wEYdT-S</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Vacina contra o hiv com base em células t alogênicas para induzir a imunidade celular e humoral</title><source>esp@cenet</source><creator>GUMRUKCU SERHAT</creator><creatorcontrib>GUMRUKCU SERHAT</creatorcontrib><description>vacina contra o hiv com base em células t alogênicas para induzir a imunidade celular e humoral. a presente invenção se refere aos métodos para o tratamento de um paciente que tem o vírus da imunodeficiência humana (hiv) que compreendem administrar composições celulares que compreendem células alogênicas recombinantes, tais como células cd4+t. a presente invenção se refere ainda a composições e métodos para produzir uma vacina protetora contra o hiv com base em células t alogênicas que induz à imunidade celular e humoral. Provided herein are methods for treating a patient with human immunodeficiency virus (HIV), comprising administering cellular compositions comprising recombinant allogeneic cells, such as CD4+ T cells. The present invention further relates to compositions and methods for making an allogeneic T-cell-based protective HIV vaccine that induces both cellular and humoral immunity. Related compositions and methods for modulating the immune system using such recombinant cells are also provided.</description><language>por</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220426&DB=EPODOC&CC=BR&NR=112021025286A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220426&DB=EPODOC&CC=BR&NR=112021025286A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GUMRUKCU SERHAT</creatorcontrib><title>Vacina contra o hiv com base em células t alogênicas para induzir a imunidade celular e humoral</title><description>vacina contra o hiv com base em células t alogênicas para induzir a imunidade celular e humoral. a presente invenção se refere aos métodos para o tratamento de um paciente que tem o vírus da imunodeficiência humana (hiv) que compreendem administrar composições celulares que compreendem células alogênicas recombinantes, tais como células cd4+t. a presente invenção se refere ainda a composições e métodos para produzir uma vacina protetora contra o hiv com base em células t alogênicas que induz à imunidade celular e humoral. Provided herein are methods for treating a patient with human immunodeficiency virus (HIV), comprising administering cellular compositions comprising recombinant allogeneic cells, such as CD4+ T cells. The present invention further relates to compositions and methods for making an allogeneic T-cell-based protective HIV vaccine that induces both cellular and humoral immunity. Related compositions and methods for modulating the immune system using such recombinant cells are also provided.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjsKAjEUheE0FqLu4TaWwiSi2Koo1iK2wzW54wTyIg8Ld6TbmI0ZwQVYnfPDN2Z4RakdgvQuRwQPvX7UsHDDREAW5PAyxWCCDGj8fXg7LWsFrFo7VZ46Qn22OK1QEUj68ggEfbE-opmyUYcm0ey3EzY_Hi7704KCbykFlOQot7sz56IRvBErsVlvxfJf9wEYdT-S</recordid><startdate>20220426</startdate><enddate>20220426</enddate><creator>GUMRUKCU SERHAT</creator><scope>EVB</scope></search><sort><creationdate>20220426</creationdate><title>Vacina contra o hiv com base em células t alogênicas para induzir a imunidade celular e humoral</title><author>GUMRUKCU SERHAT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112021025286A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2022</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>GUMRUKCU SERHAT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GUMRUKCU SERHAT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Vacina contra o hiv com base em células t alogênicas para induzir a imunidade celular e humoral</title><date>2022-04-26</date><risdate>2022</risdate><abstract>vacina contra o hiv com base em células t alogênicas para induzir a imunidade celular e humoral. a presente invenção se refere aos métodos para o tratamento de um paciente que tem o vírus da imunodeficiência humana (hiv) que compreendem administrar composições celulares que compreendem células alogênicas recombinantes, tais como células cd4+t. a presente invenção se refere ainda a composições e métodos para produzir uma vacina protetora contra o hiv com base em células t alogênicas que induz à imunidade celular e humoral. Provided herein are methods for treating a patient with human immunodeficiency virus (HIV), comprising administering cellular compositions comprising recombinant allogeneic cells, such as CD4+ T cells. The present invention further relates to compositions and methods for making an allogeneic T-cell-based protective HIV vaccine that induces both cellular and humoral immunity. Related compositions and methods for modulating the immune system using such recombinant cells are also provided.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	por
recordid	cdi_epo_espacenet_BR112021025286A2
source	esp@cenet
subjects	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
title	Vacina contra o hiv com base em células t alogênicas para induzir a imunidade celular e humoral
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A53%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GUMRUKCU%20SERHAT&rft.date=2022-04-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112021025286A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true